Ono Pharmaceutical Co. Lt... (OPHLF)
PNK: OPHLF
· Real-Time Price · USD
12.75
0.00 (0.00%)
At close: Apr 29, 2025, 2:09 PM
0.00% (1D)
| Bid | 9.99 |
| Market Cap | 5.99B |
| Revenue (ttm) | 500.33B |
| Net Income (ttm) | 120.95B |
| EPS (ttm) | 1.11 |
| PE Ratio (ttm) | 11.49 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 13.11 |
| Volume | 24 |
| Avg. Volume (20D) | 1,601 |
| Open | 10.22 |
| Previous Close | 12.75 |
| Day's Range | 10.22 - 12.75 |
| 52-Week Range | 9.22 - 16.05 |
| Beta | 0.74 |
About OPHLF
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VEL...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Mar 21, 2013
Employees 3,853
Stock Exchange PNK
Ticker Symbol OPHLF
Website https://www.ono-pharma.com